All too often pharmaceutical marketing orthodoxy says to focus on just one area – a product’s launch, in the belief that this is the only area that can determine success.
We all exhibit behaviours that are, at times, irrational, and this presents a major challenge for pharmaceutical companies that are developing patient support programmes.
The benefits of adherent patients are no secret: better outcomes, a more stable treatment pathway and of course better revenues for pharma are all possible.
Overview
Medical affairs and publications teams are under increasing pressure to demonstrate effectively the success of the medical communications activities they undertake.
The Novo Nordisk Foundation, the Bill & Melinda Gates Foundation, and Wellcome have joined forces to tackle some of the most pressing threats to human health and wellb
It’s 2024, and in most clinical trials, data is still being moved from the EHR to the EDC manually – with employees reading data from one screen and typing it onto another.